China Myotonic Dystrophy Drug Market Research Report 2018

Published Date : 2018-04-17

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 103

The global Myotonic Dystrophy Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Myotonic Dystrophy Drug development status and future trend in China, focuses on top players in China, also splits Myotonic Dystrophy Drug by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
BioMarin Pharmaceutical Inc.
F. Hoffmann-La Roche Ltd.
Genzyme Corporation
Isis Pharmaceuticals, Inc.
Marina Biotech, Inc.
Valentia Biopharma S.L.
...

Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
ISIS-DMPKRx
PRO-135
SRT-152
VAL-0411
Others

On the basis of the end users/application, this report covers
Hospital
Clinic
Home Use
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

China Myotonic Dystrophy Drug Market Research Report 2018
1 Myotonic Dystrophy Drug Overview
1.1 Product Overview and Scope of Myotonic Dystrophy Drug
1.2 Classification of Myotonic Dystrophy Drug by Product Category
1.2.1 China Myotonic Dystrophy Drug Sales (K Pcs) Comparison by Type (2013-2025)
1.2.2 China Myotonic Dystrophy Drug Sales (K Pcs) Market Share by Type in 2017
1.2.3 ISIS-DMPKRx
1.2.4 PRO-135
1.2.5 SRT-152
1.2.6 VAL-0411
1.2.7 Others
1.3 China Myotonic Dystrophy Drug Market by Application/End Users
1.3.1 China Myotonic Dystrophy Drug Sales (K Pcs) and Market Share Comparison by Applications (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Use
1.3.5 Others
1.4 China Myotonic Dystrophy Drug Market by Region
1.4.1 China Myotonic Dystrophy Drug Market Size (Million USD) Comparison by Region (2013-2025)
1.4.2 South China Myotonic Dystrophy Drug Status and Prospect (2013-2025)
1.4.3 East China Myotonic Dystrophy Drug Status and Prospect (2013-2025)
1.4.4 Southwest China Myotonic Dystrophy Drug Status and Prospect (2013-2025)
1.4.5 Northeast China Myotonic Dystrophy Drug Status and Prospect (2013-2025)
1.4.6 North China Myotonic Dystrophy Drug Status and Prospect (2013-2025)
1.4.7 Central China Myotonic Dystrophy Drug Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Myotonic Dystrophy Drug (2013-2025)
1.5.1 China Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%)(2013-2025)
1.5.2 China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 China Myotonic Dystrophy Drug Market Competition by Players/Manufacturers
2.1 China Myotonic Dystrophy Drug Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Myotonic Dystrophy Drug Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Myotonic Dystrophy Drug Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 China Myotonic Dystrophy Drug Market Competitive Situation and Trends
2.4.1 China Myotonic Dystrophy Drug Market Concentration Rate
2.4.2 China Myotonic Dystrophy Drug Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Myotonic Dystrophy Drug Manufacturing Base Distribution, Sales Area, Product Types

3 China Myotonic Dystrophy Drug Sales and Revenue by Region (2013-2018)
3.1 China Myotonic Dystrophy Drug Sales (K Pcs) and Market Share by Region (2013-2018)
3.2 China Myotonic Dystrophy Drug Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Myotonic Dystrophy Drug Price (USD/Pcs) by Regions (2013-2018)

4 China Myotonic Dystrophy Drug Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Myotonic Dystrophy Drug Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
4.2 China Myotonic Dystrophy Drug Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Myotonic Dystrophy Drug Price (USD/Pcs) by Type (2013-2018)
4.4 China Myotonic Dystrophy Drug Sales Growth Rate (%) by Type (2013-2018)

5 China Myotonic Dystrophy Drug Sales by Application (2013-2018)
5.1 China Myotonic Dystrophy Drug Sales (K Pcs) and Market Share by Application (2013-2018)
5.2 China Myotonic Dystrophy Drug Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 China Myotonic Dystrophy Drug Players/Suppliers Profiles and Sales Data
6.1 BioMarin Pharmaceutical Inc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Myotonic Dystrophy Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Myotonic Dystrophy Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.2.4 Main Business/Business Overview
6.3 Genzyme Corporation
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Myotonic Dystrophy Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Genzyme Corporation Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.3.4 Main Business/Business Overview
6.4 Isis Pharmaceuticals, Inc.
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Myotonic Dystrophy Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.4.4 Main Business/Business Overview
6.5 Marina Biotech, Inc.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Myotonic Dystrophy Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Marina Biotech, Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.5.4 Main Business/Business Overview
6.6 Valentia Biopharma S.L.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Myotonic Dystrophy Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
6.6.4 Main Business/Business Overview
...

7 Myotonic Dystrophy Drug Manufacturing Cost Analysis
7.1 Myotonic Dystrophy Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Myotonic Dystrophy Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Myotonic Dystrophy Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Myotonic Dystrophy Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 China Myotonic Dystrophy Drug Market Size (Sales and Revenue) Forecast (2018-2025)
11.1 China Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
11.2 China Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Type (2018-2025)
11.3 China Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Application (2018-2025)
11.4 China Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List



List of Tables and Figures

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Myotonic Dystrophy Drug Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Myotonic Dystrophy Drug Sales (K Pcs) by Application (2013-2025)
Figure Product Picture of Myotonic Dystrophy Drug
Table China Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Myotonic Dystrophy Drug Sales Volume Market Share by Types in 2017
Figure ISIS-DMPKRx Product Picture
Figure PRO-135 Product Picture
Figure SRT-152 Product Picture
Figure VAL-0411 Product Picture
Figure Others Product Picture
Figure China Myotonic Dystrophy Drug Sales (K Pcs) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Myotonic Dystrophy Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Use Examples
Table Key Downstream Customer in Home Use
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Myotonic Dystrophy Drug Sales of Key Players/Manufacturers (2013-2018)
Table China Myotonic Dystrophy Drug Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Myotonic Dystrophy Drug Sales Share (%) by Players/Manufacturers
Figure 2017 China Myotonic Dystrophy Drug Sales Share (%) by Players/Manufacturers
Table China Myotonic Dystrophy Drug Revenue by Players/Manufacturers (2013-2018)
Table China Myotonic Dystrophy Drug Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Myotonic Dystrophy Drug Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Myotonic Dystrophy Drug Revenue Market Share (%) by Players/Manufacturers
Table China Market Myotonic Dystrophy Drug Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Myotonic Dystrophy Drug Average Price of Key Players/Manufacturers in 2017
Figure China Myotonic Dystrophy Drug Market Share of Top 3 Players/Manufacturers
Figure China Myotonic Dystrophy Drug Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Myotonic Dystrophy Drug Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Myotonic Dystrophy Drug Product Category
Table China Myotonic Dystrophy Drug Sales (K Pcs) by Regions (2013-2018)
Table China Myotonic Dystrophy Drug Sales Share (%) by Regions (2013-2018)
Figure China Myotonic Dystrophy Drug Sales Share (%) by Regions (2013-2018)
Figure China Myotonic Dystrophy Drug Sales Market Share (%) by Regions in 2017
Table China Myotonic Dystrophy Drug Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Myotonic Dystrophy Drug Revenue Market Share (%) by Regions (2013-2018)
Figure China Myotonic Dystrophy Drug Revenue Market Share (%) by Regions (2013-2018)
Figure China Myotonic Dystrophy Drug Revenue Market Share (%) by Regions in 2017
Table China Myotonic Dystrophy Drug Price (USD/Pcs) by Regions (2013-2018)
Table China Myotonic Dystrophy Drug Sales (K Pcs) by Type (2013-2018)
Table China Myotonic Dystrophy Drug Sales Share (%) by Type (2013-2018)
Figure China Myotonic Dystrophy Drug Sales Share (%) by Type (2013-2018)
Figure China Myotonic Dystrophy Drug Sales Market Share (%) by Type in 2017
Table China Myotonic Dystrophy Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Myotonic Dystrophy Drug Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Myotonic Dystrophy Drug by Type (2013-2018)
Figure Revenue Market Share of Myotonic Dystrophy Drug by Type in 2017
Table China Myotonic Dystrophy Drug Price (USD/Pcs) by Types (2013-2018)
Figure China Myotonic Dystrophy Drug Sales Growth Rate (%) by Type (2013-2018)
Table China Myotonic Dystrophy Drug Sales (K Pcs) by Applications (2013-2018)
Table China Myotonic Dystrophy Drug Sales Market Share (%) by Applications (2013-2018)
Figure China Myotonic Dystrophy Drug Sales Market Share (%) by Application (2013-2018)
Figure China Myotonic Dystrophy Drug Sales Market Share (%) by Application in 2017
Table China Myotonic Dystrophy Drug Sales Growth Rate (%) by Application (2013-2018)
Figure China Myotonic Dystrophy Drug Sales Growth Rate (%) by Application (2013-2018)
Table BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Basic Information List
Table BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Sales Market Share (%) in China (2013-2018)
Figure BioMarin Pharmaceutical Inc. Myotonic Dystrophy Drug Revenue Market Share (%) in China (2013-2018)
Table F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Basic Information List
Table F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Sales Market Share (%) in China (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Myotonic Dystrophy Drug Revenue Market Share (%) in China (2013-2018)
Table Genzyme Corporation Myotonic Dystrophy Drug Basic Information List
Table Genzyme Corporation Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Genzyme Corporation Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Genzyme Corporation Myotonic Dystrophy Drug Sales Market Share (%) in China (2013-2018)
Figure Genzyme Corporation Myotonic Dystrophy Drug Revenue Market Share (%) in China (2013-2018)
Table Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Basic Information List
Table Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Sales Market Share (%) in China (2013-2018)
Figure Isis Pharmaceuticals, Inc. Myotonic Dystrophy Drug Revenue Market Share (%) in China (2013-2018)
Table Marina Biotech, Inc. Myotonic Dystrophy Drug Basic Information List
Table Marina Biotech, Inc. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Marina Biotech, Inc. Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Marina Biotech, Inc. Myotonic Dystrophy Drug Sales Market Share (%) in China (2013-2018)
Figure Marina Biotech, Inc. Myotonic Dystrophy Drug Revenue Market Share (%) in China (2013-2018)
Table Valentia Biopharma S.L. Myotonic Dystrophy Drug Basic Information List
Table Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Valentia Biopharma S.L. Myotonic Dystrophy Drug Sales Market Share (%) in China (2013-2018)
Figure Valentia Biopharma S.L. Myotonic Dystrophy Drug Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Myotonic Dystrophy Drug
Figure Manufacturing Process Analysis of Myotonic Dystrophy Drug
Figure Myotonic Dystrophy Drug Industrial Chain Analysis
Table Raw Materials Sources of Myotonic Dystrophy Drug Major Players/Manufacturers in 2017
Table Major Buyers of Myotonic Dystrophy Drug
Table Distributors/Traders List
Figure China Myotonic Dystrophy Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure China Myotonic Dystrophy Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Myotonic Dystrophy Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table China Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Myotonic Dystrophy Drug Sales Volume Market Share Forecast by Type in 2025
Table China Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure China Myotonic Dystrophy Drug Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Myotonic Dystrophy Drug Sales Volume Market Share Forecast by Application in 2025
Table China Myotonic Dystrophy Drug Sales (K Pcs) Forecast by Regions (2018-2025)
Table China Myotonic Dystrophy Drug Sales Volume Share Forecast by Regions (2018-2025)
Figure China Myotonic Dystrophy Drug Sales Volume Share Forecast by Regions (2018-2025)
Figure China Myotonic Dystrophy Drug Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Myotonic Dystrophy Drug  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com